MedPath

The effect of capsaicin and cinnamaldehyde on intestinal permeability, gallbladder motility and satiety

Completed
Conditions
gallbladder motility
leaky gut
10017977
Registration Number
NL-OMON34052
Lead Sponsor
niversiteit Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

1) Based on medical history and previous examination, no gastrointestinal complaints can be defined.
2) Age between 18 and 65 years
3) BMI between 20 and 30 kg/m2

Exclusion Criteria

1) History of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/¬connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological/¬psychiatric diseases, allergy, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol. The severity of the disease (major interference with the execution of the experiment or potential influence on the study outcomes) will be decided by the principal investigator.
2) Use of medication, including vitamin supplementation, except oral contraceptives, within 14 days prior to testing
3) Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study
4) Major abdominal surgery interfering with gastrointestinal function (uncomplicated appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon judgement of the principle investigator)
5) Dieting (medically prescribed, vegetarian, diabetic, macrobiological, biological dynamic), pregnancy, lactation
6) Excessive alcohol consumption (>20 alcoholic consumptions per week)
7) Smoking
8) Blood donation within 3 months before the study period
9) Self-admitted HIV-positive state

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary aim is to assess intestinal permeability by means of sugar<br /><br>permeability test </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary outcomes of the study are to assess tight junction functionality in<br /><br>duodenal biopsy specimens and to assess gallbladder motility and effects on<br /><br>satiety.</p><br>
© Copyright 2025. All Rights Reserved by MedPath